Fund Holdings — Euclidean Capital LLC

Total Portfolio Value:
$266.12M
Total Bought:
$62.65M
Total Sold:
$522.98M
Net Transaction:
-$460.33M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Ishares TrMSCI INDIA ETF
MSCI INDIA ETF
2,425,1442,425,1440$127.66M$124.85M46.91%-$2.81M
Vanguard Intl Equity Index FALLWRLD EX US1,013,4341,991,884+978,450$58.18M$120.83M45.40%+$62.65M
Foghorn Therapeutics Inc.(FHTX)1,573,7611,573,7610$7.43M$5.74M2.16%-$1.68M
ORIC Pharmaceuticals, Inc.(ORIC)989,410989,4100$7.98M$5.52M2.07%-$2.46M
PMV Pharmaceuticals, Inc.(PMVP)2,627,6432,627,6430$3.97M$2.86M1.08%-$1.10M
State Street SPDR S&P 500 ETF TrustTR UNIT(SPY)896,2544,104-892,150$525.28M$2.30M0.86%-$522.98M
Alector Inc1,307,8581,307,8580$2.47M$1.61M0.60%-$863.2K
Surrozen, Inc.(SRZN)87,69687,6960$1.26M$1.02M0.38%-$235.9K
Rapt Therapeutics Inc657,899657,8990$1.04M$802.6K0.30%-$236.8K
Tenaya Therapeutics, Inc.(TNYA)1,015,7051,015,7050$1.45M$579.1K0.22%-$873.4K
Surrozen, Inc.W EXP 08 01 203(SRZN)170,833170,8330$3.7K$5.1K0.00%+$1.5K
Page 1 of 1
Euclidean Capital LLC — 13F Holdings — Q1 2025 | TickerTrail